Products
Platform
Research
Market
Learn
Compare Tata India Pharma & Healthcare Fund vs SBI Healthcare Opportunities Fund
Fund Comparison
Detailed comparison on parameters like NAV | Returns | Risk | Rating | Analysis
Fund Details
Risk | Very High | Very High |
Rating | 3.0 | 5.0 |
Min SIP Amount | ₹100 | ₹500 |
Expense Ratio | 2.1 | 1.93 |
NAV | ₹31.01 | ₹435.81 |
Fund Started | 04 Dec 2015 | 04 Jun 1999 |
Fund Size | ₹1308.56 Cr | ₹3963.38 Cr |
Exit Load | Exit load of 0.25% if redeemed within 30 days. | Exit load of 0.50% if redeemed within 15 days |
Risk
Very High
Very High
Rating
3.0
5.0
Min SIP Amount
₹100
₹500
Expense Ratio
2.1
1.93
NAV
₹31.01
₹435.81
Fund Started
04 Dec 2015
04 Jun 1999
Fund Size
₹1308.56 Cr
₹3963.38 Cr
Exit Load
Exit load of 0.25% if redeemed within 30 days.
Exit load of 0.50% if redeemed within 15 days
Returns
1 Year | -1.47% | 3.61% |
3 Year | 23.49% | 26.15% |
5 Year | 19.42% | 20.80% |
1 Year
-1.47%
3.61%
3 Year
23.49%
26.15%
5 Year
19.42%
20.80%
Holding Analysis
Equity | 97.44% | 96.19% |
Cash | 2.56% | 3.74% |
Equity
97.44%
96.19%
Cash
2.56%
3.74%
Top Holdings
Top 10 Holdings |
|
|
Top 10 Holdings
Name | Assets |
|---|---|
Sun Pharmaceutical Industries Ltd. | 9.94% |
Cipla Ltd. | 6.92% |
Apollo Hospitals Enterprise Ltd. | 5.15% |
Healthcare Global Enterprises Ltd. | 4.85% |
Lupin Ltd. | 4.79% |
Torrent Pharmaceuticals Ltd. | 4.58% |
Aster DM Healthcare Ltd. | 4.40% |
Alkem Laboratories Ltd. | 4.31% |
Max Healthcare Institute Ltd. | 4.05% |
Divi's Laboratories Ltd. | 3.90% |
Name | Assets |
|---|---|
Sun Pharmaceutical Industries Ltd. | 10.86% |
Divi's Laboratories Ltd. | 6.81% |
Max Healthcare Institute Ltd. | 6.12% |
Cipla Ltd. | 4.81% |
Lonza Group Ag | 4.24% |
Lupin Ltd. | 4.02% |
Torrent Pharmaceuticals Ltd. | 3.59% |
Mankind Pharma Ltd. | 3.49% |
Fortis Healthcare Ltd. | 3.45% |
Gland Pharma Ltd. | 3.31% |
Fund Manager
Name | Meeta Shetty | Tanmaya Desai |
Start Date | 01 Nov 2019 | 27 Jun 2011 |
Name
Meeta Shetty
Tanmaya Desai
Start Date
01 Nov 2019
27 Jun 2011
About Fund
Description | The scheme seeks long term capital appreciation by investing atleast 80% of it's net assets in equity/equity related instruments of the companies in the pharma & healthcare sectors in India. | The scheme seeks to provide the investors with the opportunity of long-term capital appreciation by investing in a diversified portfolio of equity and equity related securities in Healthcare space. |
Launch Date | 04 Dec 2015 | 04 Jun 1999 |
Description
The scheme seeks long term capital appreciation by investing atleast 80% of it's net assets in equity/equity related instruments of the companies in the pharma & healthcare sectors in India.
The scheme seeks to provide the investors with the opportunity of long-term capital appreciation by investing in a diversified portfolio of equity and equity related securities in Healthcare space.
Launch Date
04 Dec 2015
04 Jun 1999
